These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6127649)

  • 1. Current psychopathological theories of tardive dyskinesia and their implications for future research.
    Ananth J
    Neuropsychobiology; 1982; 8(4):210-22. PubMed ID: 6127649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tardive dyskinesia: a role for the endogenous opioid system.
    Sandyk R
    Med Hypotheses; 1986 Jan; 19(1):71-4. PubMed ID: 2871480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal models of tardive dyskinesia--a review.
    Kulkarni SK; Naidu PS
    Indian J Physiol Pharmacol; 2001 Apr; 45(2):148-60. PubMed ID: 11480221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tardive dyskinesia: clinical, biological, and pharmacological perspectives.
    Berger PA; Rexroth K
    Schizophr Bull; 1980; 6(1):102-16. PubMed ID: 6102788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [What is the connection between Parkinson disease and tardive dyskinesia?].
    Gunne LM; Andrén PE
    Lakartidningen; 1994 Aug; 91(34):2953-5. PubMed ID: 7990538
    [No Abstract]   [Full Text] [Related]  

  • 6. Tardive dyskinesia: review and update.
    Klawans HL; Goetz CG; Perlik S
    Am J Psychiatry; 1980 Aug; 137(8):900-8. PubMed ID: 6106395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I tardive dyskinesia induced by anticholinergic drugs, dopamine agonists and neuroleptics.
    Chouinard G; Steinberg S
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):571-8. PubMed ID: 6131490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine, GABA, cholecystokinin and opioids in neuroleptic-induced tardive dyskinesia.
    Ebadi M; Hama Y
    Neurosci Biobehav Rev; 1988; 12(3-4):179-87. PubMed ID: 2906420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic-induced tardive dyskinesia.
    Jenner P; Marsden CD
    Acta Psychiatr Belg; 1987; 87(5):566-98. PubMed ID: 2897761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tardive dyskinesia.
    Gerlach J
    Dan Med Bull; 1979 Aug; 26(5):209-45. PubMed ID: 40756
    [No Abstract]   [Full Text] [Related]  

  • 12. Side effects in preventive maintenance therapy with neuroleptics with special emphasis on tardive dyskinesia.
    Logothetis J; Paraschos A; Frangos E
    Bibl Psychiatr; 1981; (160):22-9. PubMed ID: 6109528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on tardive dyskinesia.
    Simpson GM; Pi EH; Sramek JJ
    Hosp Community Psychiatry; 1986 Apr; 37(4):362-9. PubMed ID: 2870977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic trials in tardive dyskinesia.
    Villeneuve A
    Can Psychiatr Assoc J; 1978 Oct; 23(6):411-5. PubMed ID: 30534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity?
    Jeste DV; Wyatt RJ
    J Clin Psychiatry; 1981 Dec; 42(12):455-7. PubMed ID: 6118358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study.
    Rondot P; Bathien N
    Adv Neurol; 1987; 45():361-6. PubMed ID: 2881446
    [No Abstract]   [Full Text] [Related]  

  • 17. Dyskinesia induced by long-term treatment with antipsychotic drugs: involvement of pre- and postsynaptic dopaminergic mechanisms.
    Engel J; Liljequist S; Goldstein M
    Adv Biochem Psychopharmacol; 1980; 23():387-95. PubMed ID: 6104913
    [No Abstract]   [Full Text] [Related]  

  • 18. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
    Bitton V; Melamed E
    J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotransmitter interactions related to central dopamine neurons.
    Lloyd KG
    Essays Neurochem Neuropharmacol; 1978; 3():129-207. PubMed ID: 30628
    [No Abstract]   [Full Text] [Related]  

  • 20. A therapeutic approach to tardive dyskinesia.
    Fahn S
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):19-24. PubMed ID: 2858474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.